University of Illinois at Chicago

UIC joins registry of COVID-19 frontline care providers, preventive drug trial

Health care workers can now participate in HERO research program

Newswise — Health care workers at the University of Illinois Hospital and Health Sciences System, or UI Health, are now eligible to participate in a national registry of clinicians working on the frontlines of the COVID-19 pandemic.

UI Health is part of the University of Illinois at Chicago, which is among the first institutions in the nation to participate in the Healthcare Worker Exposure Response and Outcomes Registry.

The HERO Registry seeks to engage health care workers, understand their experiences and track their health outcomes related to the pandemic — from COVID-19 infection to stress and burnout. Participant experiences and health outcomes will be tracked via surveys and opportunities, to participate in clinical trials.

As part of the registry, health care workers at UI Health also will have the opportunity to participate in future COVID-19 clinical trials, such as an upcoming study of hydroxychloroquine’s effectiveness in preventing coronavirus infections in health care workers. This study, the first for the HERO Registry, will enroll approximately 15,000 health care workers from participating institutions in the clinical trial to see if hydroxychloroquine performs better than placebo at preventing COVID-19.

“This is a great opportunity for our health care workers to share their experiences and the challenges they face as frontline care providers,” said UIC’s Dr. Susan Bleasdale, associate professor of clinical medicine at the College of Medicine, medical director of infection prevention at UI Health and principal investigator of the HERO hydroxychloroquine study at UIC. “We need to study what is happening among health care providers with the same dedication we study what is happening to patients.

“This information is vital to understanding what works and what doesn’t work as we start thinking through the best ways to protect health care workers, emerge from this crisis and learn from it,” said Bleasdale, who is an infectious disease expert.

Bleasdale said that documenting the experiences of health care providers in real-time during the COVID-19 pandemic can provide invaluable information to public health departments, hospitals and infectious disease experts on how to prepare for future outbreaks or a second wave of the COVID-19 pandemic.

The hydroxychloroquine study is expected to begin enrolling health care workers through the HERO registry on May 4.

The HERO research program leverages PCORnet, the National Patient-Centered Clinical Research Network, and is funded by the Patient-Centered Outcomes Research Institute.

More information about the HERO Registry, which is led by Duke University, is available online.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3423
access_time Embargo lifts in 2 days
Embargo will expire: 30-Sep-2020 10:00 PM EDT Released to reporters: 28-Sep-2020 5:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2020 10:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 28-Sep-2020 5:10 PM EDT
COVID-19 may deplete testosterone, helping to explain male patients' poorer prognosis
Taylor & Francis

For the first time, data from a study with patients hospitalized due to COVID-19 suggest that the disease might deteriorate men's testosterone levels.

access_time Embargo lifts in 2 days
Embargo will expire: 30-Sep-2020 11:00 AM EDT Released to reporters: 28-Sep-2020 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 28-Sep-2020 4:55 PM EDT
Covid-19: Social distancing is more effective than travel bans
University of Southern Denmark

Forecasting the spreading of a pandemic is paramount in helping governments to enforce a number of social and economic measures, apt at curbing the pandemic and dealing with its aftermath.

Released: 28-Sep-2020 1:55 PM EDT
mRNA-based COVID-19 vaccines will NOT modify the human genome
Newswise

There is no evidence that mRNA-based COVID-19 vaccines will use hydrogels. There is no evidence of a hydrogel chip that will connect you to the internet or alter your DNA.

Released: 28-Sep-2020 12:20 PM EDT
Missing Rehab Due to COVID-19 Increased Distress in Women with Breast Cancer
Wolters Kluwer Health: Lippincott

Beyond the tragic surges in hospitalizations and deaths, the first months of the COVID-19 pandemic disrupted healthcare for people with a wide range of medical conditions – including cancer. For women recovering after breast cancer treatment, COVID-19-related interruptions in rehabilitation care led to emotional distress and other effects on health and well-being, reports a study in the October issue of Rehabilitation Oncology, official journal of the APTA Oncology, an Academy of the American Physical Therapy Association. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Marriott Library digital exhibit finds echoes of today’s pandemic news in century-old headlines
Released: 28-Sep-2020 12:05 PM EDT
Marriott Library digital exhibit finds echoes of today’s pandemic news in century-old headlines
University of Utah

The J. Willard Marriott Library is launching a new digital exhibit to explore the 1918 flu pandemic in Utah through contemporary newspaper articles. The articles show how the issues and divisions that have appeared in the COVID-19 pandemic are, unfortunately, nothing new.

Newswise: Presidential Debates in a Highly Polarized America: UNLV Expert Available
Released: 28-Sep-2020 11:20 AM EDT
Presidential Debates in a Highly Polarized America: UNLV Expert Available
University of Nevada, Las Vegas (UNLV)

The COVID-19 pandemic. Race relations. The Supreme Court. The economy. When President Donald Trump and former Vice President Joe Biden meet for the first of three presidential debates on Tuesday night, millions of viewers are expected to tune in. But will America really be listening? Given the country’s all-time high partisanship and the extremely tiny pool of voters who have yet to make up their minds five weeks out from the 2020 general election, analysts are putting in their bets on the influence of televised debates and the chances of actually swaying voters.

Released: 28-Sep-2020 11:05 AM EDT
The Latest on the Moderna and Johnson Johnson COVID Vaccine Trials: Expert Panel on Oct 7th, 2pm EDT
Newswise

The Latest on the Moderna and Johnson Johnson COVID Vaccine Trials: Expert Panel on Oct 7th, 2pm EDT

Released: 28-Sep-2020 11:00 AM EDT
Researchers Identify “Druggable” Signaling Pathway that Stimulates Lung Tissue Repair
Children's Hospital of Philadelphia

Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have identified a cellular pathway that can be targeted with a naturally occurring drug to stimulate lung tissue regeneration, which is necessary for recovery from multiple lung injuries. The findings, which were published today in Nature Cell Biology, could lead to better therapies for patients with lung disease, including acute respiratory distress syndrome (ARDS) due to COVID-19.


Showing results

110 of 3423

close
1.36261